Eli Lilly is integrating quantum computing to enhance drug discovery processes, promising faster simulations and predictions. This technological advancement could reduce time-to-market for new medications and boost the company’s competitive edge. Early adoption of quantum computing may offer strategic advantages, potentially increasing